Stocks and InvestingStocks and Investing
Wed, October 24, 2018
Tue, October 23, 2018
Mon, October 22, 2018
Fri, October 19, 2018
Thu, October 18, 2018
Wed, October 17, 2018
Tue, October 16, 2018

Charles Duncan Maintained (ACAD) at Buy with Increased Target to $27 on, Oct 16th, 2018


Published on 2024-10-26 09:33:49 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $25 to $27 on, Oct 16th, 2018.

Charles has made no other calls on ACAD in the last 4 months.



There are 3 other peers that have a rating on ACAD. Out of the 3 peers that are also analyzing ACAD, 1 agrees with Charles's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matteis Paul of "Stifel" Maintained at Hold with Decreased Target to $14 on, Thursday, August 9th, 2018


These are the ratings of the 2 analyists that currently disagree with Charles


  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $25 on, Wednesday, October 10th, 2018
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $27 on, Thursday, August 9th, 2018